Searched for
CIPLA Q1
Domino effect: Gandhar Oil’s 20% upper circuit spurs rally in Savita Oil and Panama Petro. Here’s whyGandhar Oil Refinery hit the 20% upper circuit after reporting a 689% year-on-year jump in Q1 net profit, triggering a rally in peers Savit...- Cipla Q1 Results: Cons profit drops 39% YoY to Rs 789 crore; revenue rises marginallyCipla Q1 Results: Pharma major Cipla reported a 39% year-on-year decline in Q1FY27 consolidated net profit to Rs 789 crore, mainly due to a...
- Stocks in news: Infosys, IndusInd Bank, Eternal, Adani Green, Dr Reddy'sIndian markets experienced a decline on Wednesday due to global and geopolitical concerns. IndusInd Bank reported a significant profit incr...
- Why did market fall today? 7 triggers behind Rs 4 lakh crore wealth wipeoutIndian stock markets experienced significant declines on Wednesday. Escalating Iran-US tensions and tariff threats spooked investors, causi...
- Domestic formulations, chronic therapies to drive Pharma Q1; US generics remain dragThe healthcare sector anticipates strong growth in domestic formulations and emerging markets. Companies with less US generics dependence w...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsOil is crucial for every part of the Indian economy: From government to consumer, its price impacts spending by every stakeholder. So, till...
- Market wrap: Trent, Axis Bank among top gainers and losers on Nifty and Sensex todayIndian equities ended lower as escalating Iran-US tensions and surging crude prices dampened investor sentiment despite easing volatility. ...
- Q1 earnings this week: Infosys, Eternal, Bajaj Auto among 256 companies set to announce June quarter resultsThe Q1 FY27 earnings season gathers momentum this week, with 256 companies scheduled to announce their April-June quarter results. Key name...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsOver the next few trading sessions, the direction of indices like the Nifty and Sensex will be determined by news on ceasefire violations a...
- Airtel to Trent: 44 cos likely to report double-digit profit slump in Q1. Are your stocks on the list?Motilal Oswal expects 44 companies, including Bharti Airtel, Trent, IndiGo, HAL, GAIL and Cipla, to report double-digit year-on-year profit...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 25%As the market makes an attempt to move upward, there is a clear preference for sectors that are focused on the domestic market. Given this,...
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
- Q4 earnings review: Motilal Oswal highlights broad-based beat on estimates, lists 6 sectors that exceeded expectationsMotilal Oswal said Q4 FY26 earnings surpassed expectations, with aggregate profits rising 16% year-on-year against its 8% estimate. Strong ...
- Bonus issues, dividends and more: Reliance Industries, Trent among 20 stocks turning ex-date this weekReliance Industries, Trent, and 18 other stocks are set to turn ex-date this week for corporate actions including dividends and bonus issue...
- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- Cipla Q1 Results: Cons PAT rises 10% YoY to Rs 1,298 crore, revenue up 4%Cipla Q1 Results: Cipla reported a 10% YoY increase in consolidated net profit, reaching Rs 1,298 crore for the June quarter, driven by a 4...
- Cipla Q1 Results: Cons PAT rises 18% YoY to Rs 1,178 crore, beats estimatesCipla Q1 Results: The profit beat the ET Now Poll estimates of Rs 1,071 crore. Revenue from operations in the reporting period increased 6%...
- Cipla Q1 results: Consolidated PAT rises 24% YoY, beats estimate; sales jump 27%The pharmaceutical major reported a 27 per cent rise in income from operations to Rs. 5,504 crore for the quarter ended June, which was als...
Load More
